期刊文献+

Rho激酶在房颤患者左心耳中的表达

Expression of Rho associated coil forming protein kinase in left atrial appendage of patients with atrial fibrillation
下载PDF
导出
摘要 目的研究Rho激酶(ROCK-1)及其底物—肌球蛋白磷酸酶靶亚基1(MYPT-1)在房颤患者左心耳中的表达,探讨Rock信号转导通路在房颤发生中的作用。方法 40例接受开胸手术者分为房颤组和窦性心律组,手术中取约100 mg左心耳组织。采用免疫组化ABC法检测两组左心耳组织的蛋白表达水平。结果 ROCK-1和MYPT-1在房颤患者左心耳中表达较对照组明显上调,差异有统计学意义(P<0.01)。房颤组ROCK-1和MYPT-1的蛋白表达,二者呈显著正相关(r=0.981,P<0.01)。结论房颤患者左心耳组织中明显存在ROCK-1表达上调与功能活化,提示Rho激酶信号转导通路在房颤病变的发生机制中具有重要作用。 Objective To detect the expressions of Rho associated coil forming protein kinase - 1 ( ROCK - 1 ) and its substrate myosin phosphatase target subunit - 1 ( MYPT - 1 ) in left atrial appendage of patients with atrial fibrillation (AF). Methods Left atrial appendage tis- sue samples of 40 patients undergoing cardiac surgery were examined. 20 patients had AF, 20 patients had no history of AF. The expressions of ROCK - 1 and MYPT - 1 in left atrial appendage were detected by immunohistochemistry. Results Immunohistochemistry showed that the expres- sions of ROCK - 1 and MYPT - 1 were significantly up - regulated in left atrial appendage of AF patients ( P 〈0. O1 ). The two indicators were positively correlated ( r =0. 981, P 〈 0.01 ). Conclusion The ROCK - 1 expression in left atrial appendage of patients with AF is up - regula- ted and activated, which implies that ROCK may play a significant role in the pathological changes in AF.
出处 《临床和实验医学杂志》 2015年第23期1939-1941,共3页 Journal of Clinical and Experimental Medicine
基金 甘肃省自然科学基金资助项目(编号:1308RJZA135)
关键词 房颤 左心耳 ROCK-1 MYPT-1 Atrial fibrillation Left atrial appendage Rho associated coil forming protein kinase - 1 Myosin phosphatase target subunit - 1
  • 相关文献

参考文献13

  • 1Higashi M, Shimokawa H, Hattori T, et al. Long- term inhibition of Rho - kinase suppresses angiotensin II - induced cardiovascular hyper- trophy in rats in vivo: effect on endothelial NAD (P) H oxidase system [J]. Circ Res,2003,93(8) :767 -775.
  • 2Ito K, Hirooka Y, Kishi T, et al. Rho/Rho - kinase pathway in the brainstem contributes to hypertension caused by chronic nitric oxide syn- thase inhibition[J]. Hypertension,2004,43(2) :156 -162.
  • 3Zhou Q, Gensch C, Liao JK. Rho - associated coiled - coil - forming ki- nases (ROCKs) : potential targets for the treatment of atherosclerosis and vascular disease[J]. Trends Pharmacol Sci,2011,32(3) :167 - 173.
  • 4Wettsehureck N, Offermanns S. Rho/Rho -kinase mediated signaling in physiology and pathophysiology [J].J Mol Med ( Bed), 2002,80 (10) :629 -638.
  • 5Noma K, Oyama N, Liao JK. Physiological role of ROCKs in the cardiovas- cular system[J]. Am J Physiol Cell Physiol, 2006,290(3) :C661 -668.
  • 6Loirand G, Gu6rin P, Pacaud P. Rho kinases in cardiovascular physiol- ogy and pathophysiology [ J ]. Cire Res,2006, 98 (3) :322 - 334.
  • 7Shimokawa H, Takeshita A. Rho - kinase is an important therapeutic target in cardiovascular medicine [ J ]. Arterioseler Thromb Vase Biol, 2005,25 (9) : 1767 - 1775.
  • 8Mare V, Tanbe AF, Vitali SH, et al. Impaired vasoconstriction and ni- tric oxide - mediated relaxation in pulmonary arteries of hypoxia - and monocrotaline - induced pulmonary hypertensive rats [ J ]. J Phannacol Exp Ther,2010,332(2) : 455 -462.
  • 9Nossaman BD, Nossaman VE, Murthy SN, et al. Role of the RhoA/ Rho- kinase pathway in the regulation of pulmonary vasoconstrictor function [ J]. Can J Physiol Pharmaco1,2010,88 ( 1 ) : 1 - 8.
  • 10Furuyama T, Komori K, Shimokawa H, et al. Long - term inhibition of Rho kinase suppresses intimal thickening in autologous vein grafts in rabbits[ J]. J Vasc Surg,2006,43 (6) : 1249 - 1256.

二级参考文献15

  • 1荆志成.2010年中国肺高血压诊治指南[J].中国医学前沿杂志(电子版),2011,3(2):62-81. 被引量:118
  • 2孙波 孙文利.右心导管测定大鼠肺动脉高压的实验方法[J].中国医学科学院学报,1984,6(6):465-465.
  • 3Humbert M, Sitben O, Simonneau G, et al. Treatment of pulmonary arterial hypertension. N Engl J Med,2004,351:1425-1436.
  • 4Gaine SP, Rubin LI. Primary pulmonary hypertension. Lancet, 1998,352:719-725.
  • 5Higashi M, Shimokawa H, Hattori T, et al. Long-term inhibition of Rho-kinase suppresses angiotensin H-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD (P)H oxidase system. Cite Res,2003,93:767-775.
  • 6Liu XR, Zhang MF, Yang N,et al. Enhanced store-operated Ca2 + entry and TRPC channel expression in pulmonary arteries of monocrotaline-induced pulmonary hypertensive rats. Am J Physiol Cell Physiol,2012,302 : C77-C87.
  • 7Mouchaers KT, Schalij I, de Boer MA, et al. Fasudil reduces monoerotaline-indueed pulmonary arterial hypertension:comparison with bosentan and sildenafil. Eur Respir J ,2010,36:800-807.
  • 8Abe K, Shimokawa H, Morikawa K, et at. Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats. Circ Res,2004,94 : 385-393.
  • 9Shi J,Zhang YW,Summers LJ, et al. Disruption of ROCKI gene attenuates cardiac dilation and improves contractile function in pathological cardiac hypertrophy. J Mol Cell Cardiol, 2008,44: 551-560.
  • 10Vallerie V, Melaughlin, Michael D, et al. Pulmonary arterial hypertension. Circulation ,2006,114 : 1417-1431.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部